Is The Fortis Board Focused On Value Maximisation?
A fifth bidder, Radiant Life Care Pvt. Ltd., joined the race for Fortis Hospitals Ltd. today but it has started at the losing end. Because the Fortis board has said it will evaluate only binding bids.
That narrows the field to offers made by Manipal Health Enterprise Pvt Ltd., and the Burman and Munjal combine. Malaysia's IHH Healthcare Bhd and the Chinese conglomerate Fosun International have, along with Radiant, been left out in the cold. Even though all five bidders have offered similarly priced offers.
But in leaving them out has the board compromised its ability to maximise value for shareholders?
One key reason for why these bidders may not have made binding offers is the lack of an opportunity to do due diligence. Especially as the company's auditor recently red flagged several inter-corporate deposits and outstanding vendor payments.
"They need to lay all their cards out on the table," said Amit Tandon, founder of proxy advisory firm IiAS. Arguing in favour of opening up the process to all bidders Tandon said Fortis Healthcare needs to prepare a vendor due diligence report and share it with bidders so as to allow for time-bound due diligence. The bidders will then be in a better position to value the assets and bid competitively.
"Opening this up to all bidders will not hurt the deal and the company in any fashion."
Also Read: KKR-Backed Radiant Life Care Joins The Race To Acquire Fortis Healthcare
Mohit Burman, a shareholder of Fortis and a qualified bidder disagreed with Tandon. "The business needs money, ASAP," he told BloombergQuint, adding that five bidders will not increase the value of the company. "Allowing five companies to do due diligence will only harm the business" given that it is in urgent need of capital for functioning. Going through he company's liabilities will take another one to two months, he added.
Interestingly the Burman-Munjal offer is focused on capital infusion and not acquisition of Fortis. Yesterday the combine presented a revised offer of Rs 1,500 crore of which Rs 750 crore will be invested upfront, without any due dilligence, to keep the hospitals running, according to a press statement.
Manipal's offer proposes a takeover of Fortis whereby its hospitals business would be merged with Manipal. It's offer values Fortis at Rs 156 per share, as does Fosun. IHH has proposed Rs 160 per share and Radient values the company at Rs 165 per share.
Apples And Oranges
Will the difference in approach between the two bidders who have made binding offers further complicate the job facing an external advisory committee appointed to assist Fortis board in evaluating bids?
It's a complexity the board and advisory committee will have to deal with, Tandon said. “People compare apples with oranges all the time, the best example being rating agencies. They have to deal with this complexity.”
Burman said it was a choice between a simple offer and a complex one. “Our offer is to save the business, with a capital infusion in the company,” he said adding that anything complex will only take away value from the company's true focus - its hospitals.
Munjals And Burmans Improve Their Offer For Fortis Healthcare
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.